PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2107273
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2107273
The natural language processing (NLP) in healthcare & life sciences market is projected to grow from USD 8.14 billion in 2026 to USD 30.06 billion by 2031, at a CAGR of 29.9% during the forecast period. Growth is being driven by increasing adoption of generative AI, medical large language models (LLMs), and cloud-based healthcare AI platforms to process unstructured clinical and scientific data.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2021-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion) |
| Segments | Offering, Technology, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Middle East & Africa, and Latin America |
Healthcare providers, payers, pharmaceutical companies, biotechnology firms, and research organizations are deploying NLP across electronic health records (EHRs), clinical documentation, medical coding, biomedical literature mining, pharmacovigilance, clinical trials, patient engagement, and administrative workflows. The rapid expansion of ambient AI, retrieval-augmented generation (RAG), and conversational AI is enabling organizations to improve clinician productivity, research efficiency, operational performance, and decision-making. However, regulatory compliance, patient data privacy, interoperability challenges, explainability requirements, and integration complexity continue to influence enterprise adoption.

"Clinical care intelligence to be fastest-growing application as healthcare organizations reduce administrative burden and improve care delivery"
By application, the clinical care intelligence segment is expected to register the fastest growth during the forecast period. Healthcare organizations are increasingly adopting NLP solutions to automate clinical note generation, ambient documentation, medical transcription, coding assistance, and physician workflow optimization. AI-powered documentation platforms help reduce clinician burnout, improve documentation accuracy, accelerate reimbursement cycles, and enhance regulatory compliance. Advances in speech recognition, generative AI, medical LLMs, and real-time clinical summarization are further expanding adoption across hospitals, physician practices, and integrated healthcare systems. Vendors offering secure, interoperable, and workflow-integrated clinical documentation solutions are expected to benefit from the growing demand for healthcare automation and digital transformation.
"Healthcare providers to be largest end-user segment in 2026 owing to widespread enterprise adoption of AI-powered clinical workflows"
By end user, the healthcare providers segment is estimated to account for the largest market share in 2026. Hospitals, health systems, specialty clinics, and physician practices generate significant volumes of unstructured clinical data that require efficient processing for diagnosis, treatment planning, documentation, revenue cycle management, and patient engagement. The widespread adoption of electronic health records (EHRs), ambient clinical intelligence, clinical decision support systems, and AI-assisted documentation continues to drive enterprise-scale NLP deployment across provider organizations. Increasing investments in digital health infrastructure, interoperability initiatives, and clinician productivity solutions further strengthen the provider segment's market leadership.
"North America to be largest regional market in 2026 due to advanced healthcare IT infrastructure and early AI adoption"
North America is estimated to account for the largest share of the NLP in healthcare & life sciences market in 2026, led by the US, which benefits from advanced healthcare IT infrastructure, widespread EHR adoption, strong AI investments, and the presence of leading healthcare technology companies. Healthcare providers, life sciences organizations, and research institutions across the region are increasingly deploying NLP for clinical documentation, medical coding, clinical decision support, biomedical research, patient engagement, and administrative workflow automation. Asia Pacific is projected to witness the fastest growth during the forecast period, driven by rapid healthcare digitalization, expanding AI investments, increasing government support for digital health, and growing adoption of cloud-based healthcare technologies across China, India, Japan, South Korea, and Southeast Asia.
"Asia Pacific to register fastest growth during forecast period as healthcare digitalization and AI investments accelerate"
Asia Pacific is projected to be the fastest-growing regional market for NLP in healthcare & life sciences during the forecast period. The region is witnessing rapid healthcare digitalization, expanding AI investments, increasing adoption of electronic health records (EHRs), and supportive government initiatives promoting digital health and AI-enabled healthcare. Countries including China, India, Japan, South Korea, Singapore, and Australia are increasingly deploying NLP solutions for clinical documentation, medical coding, clinical decision support, patient engagement, biomedical research, pharmacovigilance, and healthcare workflow automation. Rising investments by healthcare providers, pharmaceutical and biotechnology companies, and contract research organizations (CROs), coupled with growing adoption of generative AI, medical LLMs, and cloud-based healthcare platforms, are expected to sustain the region's rapid market growth.
Breakdown of Primaries
In-depth interviews were conducted with chief executive officers (CEOs), innovation and technology directors, system integrators, and executives from various key organizations operating in the NLP in healthcare & life sciences market.
Microsoft (US), Amazon Web Services (AWS) (US), Google Cloud (US), IBM (US), Oracle (US), NVIDIA (US), GE HealthCare (US), Health Catalyst (US), Inovalon (US), IQVIA (US), John Snow Labs (US), Lexalytics (US), DeepScribe (US), Tempus AI (US), Practo (India), Press Ganey (US), WebMD (US), AMBOSS (Germany), Omega Healthcare (US), Solventum (US), Datavant (US), Abridge (US), Apixio (US), Averbis (Germany), Biofourmis (US), CloudMedx (US), Corti (Denmark), Deep 6 AI (US), Emtelligent (US), Enlitic (US), ForeSee Medical (US), Gnani.ai (India), Health Fidelity (US), Notable Health (US), Reveal HealthTech (US), Suki AI (US), Dolbey Systems (US), Oncora Medical (US), Wave Health Technologies (Taiwan), Ellipsis Health (US), DeepCure (US), and Clinithink (US) are some of the key players in the NLP in healthcare & life sciences market.
The study includes an in-depth competitive analysis of these key players in the NLP in healthcare & life sciences market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the NLP in healthcare & life sciences market by offering (software and services), technology (rule-based & symbolic NLP, statistical & classical machine learning NLP, deep learning & neural NLP, transformer-based & generative NLP, RAG-enabled NLP, and other technologies), application (clinical care intelligence, clinical data intelligence, administrative & operational intelligence, patient engagement & consumer health, clinical research intelligence, life sciences R&D intelligence, and others), end user (healthcare providers, healthcare payers, life sciences organizations, contract research organizations, government & public health, and patients & consumers), and region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the NLP in healthcare & life sciences market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements; new product & service launches; mergers and acquisitions; and recent developments associated with the NLP in healthcare & life sciences market. Competitive analysis of upcoming startups in the market ecosystem is covered in this report.
Reasons to Buy This Report
The report will provide market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall NLP in healthcare & life sciences market and its subsegments. It would help stakeholders understand the competitive landscape and gain more insights to position their business better and plan suitable go-to-market strategies. It also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.